News & events

Our winter 2019 newsletter includes the announcement of the plenary and invited speakers for the 5th One Health Aotearoa Symposium in December and introduces the new Webster Family Chair in Viral Pathogenesis. View the One Health Aotearoa Winter 2019 newsletter.

New research about an old vaccine – one that has been in use for nearly 100 years – has not only shown how effective it is but also suggests it improves our immune response to a wider range of bacteria than originally intended. BCG, Bacille Calmette-Guerin, has been used for TB vaccination since 1921. A ...

New Zealand children will play an important role in the next major global research on human immunity to influenza. This country and ESR have been selected by the US National Institutes of Health (NIH) for a US$3 million research project on how first exposure to flu viruses shapes immunity to flu throughout life. ESR Chief ...

The first New Zealand-wide study of the burden of Legionnaires’ disease has found triple the number of cases of this form of pneumonia than previously reported. The study, led by One Health Aotearoa Co-director Professor David Murdoch based at the University of Otago, Christchurch, has just been published in the Lancet Infectious Diseases. It gives the ...

One Health Aotearoa Co-director Nigel French has co-written an article about yersinia which featured in Stuff’s Catalyst section this week. The article discusses the rise of yesinioisis among humans and animals. Read the article: Yersinia infection still a mystery after 2014 outbreak in NZ

Our Autumn 2019 newsletter announces the dates of the 5th One Health Aotearoa Symposium and highlights the research of ESR’s groundwater research group.   View the One Health Aotearoa Autumn 2019 newsletter.

One Health Aotearoa researcher Dr Ayesha Verrall from the Department of Pathology and Molecular Medicine at the University of Otago’s Wellington campus is the recipient of an HRC Emerging Research First Grant. Dr Verrall receives $250,000 for a project to investigate epigenetic markers of BCG protection for M.tuberculosis. The tuberculosis (TB) vaccine BCG is the ...

Leptospirosis is a globally important multi-host, multi-pathogen disease which can be transmitted to humans from animals, with more than one million cases and 60,000 deaths annually. Humans are infected through contact with urine from infected mammals including wildlife, rodents, farmed species and pets. Associate Professor Jackie Benschop from Massey University’s School of Veterinary Science will ...